title: Pylephlebitis and pyogenic liver abscesses: a complication of hemorrhoidal banding.
abstract: Hemorrhoidal banding is a well-established and safe outpatient procedure. Septic complications of hemorrhoidal banding are rare but can be fatal. The first case of pylephlebitis (septic portal vein thrombosis) and pyogenic liver abscess following hemorrhoidal banding in a 49-year-old man with diabetes is reported in the present study. Risk factors, management and the role of prophylaxis in immunocompromised patients are discussed. Caution against hemorrhoidal banding in immunosuppressed patients, including patients with diabetes, is warranted.
authors.affiliation: Department of Medicine, University of Toronto, Toronto, Canada.
authors.forename: Nicole G
authors.initials: NG
authors.lastname: Chau
authors.forename: Sacha
authors.initials: S
authors.lastname: Bhatia
authors.forename: Maitreyi
authors.initials: M
authors.lastname: Raman
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D006484:Hemorrhoids / Q000601:surgery*; D006801:Humans; D016867:Immunocompromised Host; D007710:Klebsiella Infections / Q000188:drug therapy / Q000209:etiology; D007711:Klebsiella pneumoniae / Q000187:drug effects; D008026:Ligation / Q000009:adverse effects*; D008100:Liver Abscess / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D011169:Portal Vein / Q000473:pathology; D011183:Postoperative Complications; D012307:Risk Factors; D013924:Thrombophlebitis / Q000209:etiology*
chemical_list: D000890:Anti-Infective Agents; D002939:Ciprofloxacin